Maslan Andrew Scott 4
4 · CYTOMEDIX INC · Filed Feb 10, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Conversion
Common Stock
2012-02-08+17,922→ 87,819 total - Other
Common Stock
2012-02-08+1,000→ 88,819 total
Footnotes (2)
- [F1]The reporting person converted his shares of the Series D Convertible Preferred Stock at a conversion price of $0.558 per share.
- [F2]Represents shares of stock dividend on the Series D Convertible Preferred Stock.